Ciwon sankarar lymphoblastic mai tsanani (T-ALL)-09

Wata ɗaliba mai suna Mengmeng daga Yanjiao, Guizhou, ta sami magani mai inganci a BIOOCUS Medical Group.

Mengmeng, mace, mai shekaru 21, ta halarci asibitinmu na waje a ranar 22 ga Yuni, 2021, tare da gajiya mai ɗorewa. Gwajin jini na yau da kullun ya nuna WBC 479×10^9/L. Ƙarin gwaje-gwajen ƙashi sun tabbatar da cutar sankarar lymphoblastic mai tsanani (nau'in ƙwayoyin T). Ta yi zagaye biyu na chemotherapy, amma cutar sankarar bargo ba ta da kyau, tare da MRD (ƙaramin sauran cututtuka) a kashi 56.01%, kuma tana da cutar sankarar bargo ta tsakiya.

A ranar 13 ga Agusta, an tattara ƙwayoyin lymphocytes masu ɗauke da ƙwayoyin cuta kuma an ba da maganin chemotherapy. A ranar 30 ga Agusta, Mengmeng ta karɓi maganin CD7 CAR-T cell. Makonni biyu bayan allurar, gwajin ƙashi ya nuna cikakkiyar sassauci, rashin lafiyar MRD, da kuma kula da cutar sankarar jijiyoyin tsakiya. Ta fuskanci matsalar cytokine release syndrome (CRS) a matakin 1 ba tare da wata mummunar illa ga tsarin jijiyoyi na tsakiya ba.